Global Health Ltd.

1500.00 +73.80 ▲5.2%

22 February 2024, 04:01:00 PM
Volume: 14,115

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.medanta.org
Market Cap 39,949.00 Cr.
Enterprise Value(EV) 39,415.23 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 16.83 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 88.41 Trailing Twelve Months Ending 2023-12
Industry PE 71.32 Trailing Twelve Months Ending 2023-12
Book Value / Share 103.47 Trailing Twelve Months Ending 2023-12
Price to Book Value 14.38 Calculated using Price: 1,488.15
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 26.84 Cr. 268,447,382 Shares
FaceValue 2
About Global Health Ltd.
Global Health is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India. The company has key specialities in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urology.

Global Health Ltd. Delivery

Delivered Qty
Traded Qty

Global Health Ltd. Performance

1 Day
+5.17%
1 Week
+13.64%
1 Month
+37.54%
3 Month
+67.86%
6 Month
+117.75%
1 Year
+195.51%
2 Year
5 Year
10 Year

Global Health Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 17.43 18.36 4.87 3.03 5.24 2.92 2.23 13.4 16.17
Return on Capital Employed (%) 25.32 26.12 8.63 5.94 6.55 6.2 5.26 16.38 18.71
Return on Assets (%) 12.1 12.62 3.23 1.81 2.88 1.46 0.99 5.85 7.84

Global Health Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 879 1,057 1,139 1,217 1,305 1,350 1,382 1,616 2,428 2,654
Non Curr. Liab. 118 189 242 432 676 1,009 1,300 1,586 1,691 750
Curr. Liab. 214 238 272 334 279 358 405 419 573 641
Minority Int. 1 0
Equity & Liab. 1,212 1,485 1,653 1,984 2,259 2,716 3,087 3,622 4,692 4,045
Non Curr. Assets 802 976 1,025 1,512 1,769 2,237 2,585 2,810 3,112 2,683
Curr. Assets 410 509 627 472 490 479 502 812 1,579 1,362
Misc. Exp. not W/O
Total Assets 1,212 1,485 1,653 1,984 2,259 2,716 3,087 3,622 4,692 4,045

Global Health Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,194 1,382 1,277 1,343 1,441 1,500 1,447 2,167 2,694 3,153
Other Income 36 45 67 49 65 44 31 39 65 93
Total Income 1,230 1,427 1,344 1,392 1,506 1,544 1,478 2,206 2,759 3,246
Total Expenditure -932 -1,081 -1,155 -1,218 -1,299 -1,309 -1,250 -1,709 -2,074 -2,387
PBIDT 299 347 189 174 207 235 228 497 686 858
Interest -9 -14 -23 -28 -21 -57 -73 -86 -86 -76
Depreciation -64 -70 -81 -86 -91 -115 -123 -130 -150 -165
Taxation -79 -92 -35 -27 -34 -28 -4 -84 -123 -165
Exceptional Items 0
PAT 147 170 51 33 61 36 29 196 326 452
Minority Interest 1 0 0
Share Associate 0 0
Other Related Items
Consolidated Net Profit 147 170 51 33 61 36 29 196 326 452
Adjusted EPS 6 7 2 1 2 1 1 8 12 17

Global Health Ltd. Cash Flow

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 213 228 115 63 150 175 242 311 645
Cash Fr. Inv. -126 -241 -107 -69 -244 -87 -239 -421 -342
Cash Fr. Finan. -87 -7 -6 9 113 -1 -81 160 346
Net Change 0 -20 2 3 19 87 -78 50 648
Cash & Cash Eqvt 62 43 44 47 66 148 69 119 767

Global Health Ltd. Shareholding Pattern

5 Qtrs 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 33.08 33.08 33.07 33.06 33.05
Public 66.92 66.92 66.93 66.94 66.95
Depository Receipts 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00

Global Health Ltd. Announcements

Wed, 21 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir(s) Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that representatives of the following Investors/Analysts are scheduled to meet the Management of the Company as per schedule attached.
Wed, 21 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir(s) Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that representatives of the following Investors/Analysts are scheduled to meet the Management of the Company as per schedule attached.
Fri, 16 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Companys Representatives are scheduled to meet the Investors as per schedule attached in the intimation.

Global Health Ltd. Technical Scans

Thu, 22 Feb 2024
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month

Global Health Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,756.40 1,553.75 +0.7%
Cipla Ltd. 117,370.75 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. 106,155.83 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. 97,309.86 6,766.05 +0.1%
Divi's Laboratories Ltd. 96,809.75 3,642.80 -0.2%
Zydus Lifesciences Ltd. 91,584.23 904.80 +1.3%
Torrent Pharmaceuticals Ltd. 88,295.34 2,611.70 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.97 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 31.65 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.28 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 70.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.80 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,611.70 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 4.53 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.95 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.71 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,611.70 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,611.70 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,611.70 +0.4%

Global Health Ltd. FAQ's

What is Global Health share price?

Can I buy Global Health shares now?

What is the Market Cap of Global Health?

What are the key metrics to analyse Global Health?

What is the 52 Week High and Low of Global Health?

What is the trend of Global Health share price?